Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant

NCT00140907 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00140907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
March 14, 2000
Completion date
January 1, 2005
Enrollment
367 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

high blood pressure